Advances
in Patient

Safety

Safe and Efficient Anesthesia: The Role of Quantitative Neuromuscular Monitoring

 

Featured Speakers

 

Manfred Blobner, MD

Professor of Anesthesia

Department of Anaesthesiology and Intensive Care Medicine

School of Medicine,

Technical University of Munich, Germany

 

Matthias Eikermann, MD

Professor of Anesthesia

Harvard Medical School

Boston, MA

 

 

 

 

 

 

Description:

Residual neuromuscular block poses an unnecessary threat to patients. The basic principle for preventing residual neuromuscular block is quantitative neuromuscular monitoring. Three methods of neuromuscular monitoring will be addressed in this webinar: AMG, KMG and EMG. However, a combination of both neuromuscular monitoring and reversal agents, in terms of an algorithm can reduce incidence and severity of this unwanted anesthetic complication. In this webinar, the speakers discuss an algorithm using quantitative neuromuscular monitoring, to reliably detect and reverse a possible residual neuromuscular block in a particular clinical situation.

 

Learning Objectives:

Upon completion of this activity, the participant will be able to:

  1. Discuss the use of neuromuscular monitoring for the prevention residual neuromuscular block during anesthesia.
  2. Describe the three (3) technologies of neuromuscular monitoring
  3. Discuss the use of both neuromuscular monitoring and reversal agents in combination with an algorithm to reduce anesthetic complications

 

Faculty Bios:

Matthias Eikermann, MD, PhD

Dr. Matthias Eikermann is a Professor of Anesthesia at Harvard Medical School, attending anesthesiologist and Vice Chair of Faculty Affairs in the Department of Anesthesia, Critical Care and Pain Medicine at BIDMC. A current major focus of Dr. Eikermann lies in the identification of surgical patients at increased risk of ischemic stroke after surgery. Postoperative respiratory complications represent a further clinically meaningful endpoint of interest. Dr. Eikermann’s team has shown various anesthesia- related factors to be associated with adverse respiratory outcomes, such as the intraoperative use of intermediate acting neuromuscular blocking agents. Dr. Eikermann serves as the Associate Editor of the British Journal of Anesthesiology and Section Editor, Critical Care of BMC Anesthesiology. He has published over 5o papers in many peer-reviewed journals. Dr Eikermann is highly-sought after speaker and has presented at over 100 medical conferences throughout the world.

 

Manfred Blobner, MD

Professor Blobner is Senior Consultant and Vice Director of the Department of Anesthesiology and Intensive Care Medicine, School of Medicine, Technical University of Munich. During the last 26 years at the department, he inaugurated and chaired seven clinical and experimental research groups. He currently leads a research group on neuromuscular physiology and pharmacology and is chief investigator of ESA CTN’s POPULAR study. Prof. Blobner is the author of 148 manuscripts published in several international peer-reviewed journals and has been an invited speaker to many international medical conferences.

 

Continuing Education for Physicians, Nurses and Respiratory Therapists

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of SynAptiv and Saxe Healthcare Communications. SynAptiv is accredited by the ACCME to provide continuing medical education for physicians. SynAptiv designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity

 

Saxe Healthcare Communications is accredited as a provider for continuing education. Provider approved by California Board of Nursing. Provider #14477 and the Florida Board of Nursing Provider # 50-17032

This program has been approved for 1.0 contact hours Continuing Respiratory Care Education (CRCE) credit by the American Association of Respiratory Care.

 

This program has been approved for 1.0 contact hours Continuing Respiratory Care Education (CRCE) credit by the American Association of Respiratory Care.

Provider approved by California Board of Nursing, Provider # 14477 and the Florida Board of Nursing Provider # 50-17032

 

Support for this educational activity from GE Healthcare

 

©Saxe Healthcare Communications 2019

 

 

 

 

 

 

View On-Demand Webinar

Read Monograph